S. 4109 · Senate bill · 119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2026

Sponsored by Sen. Jack Reed, Rhode Island with 3 co-sponsors

Introduced Mar 17, 2026

Referred to the Health, Education, Labor, and Pensions Committee

Latest action Jun 22, 2026

SponsorSen. Jack Reed, Rhode Island· 3 cosponsorsSen. Tim Scott, South CarolinaSen. Tina Smith, Minnesota

Show 1 more cosponsor

RepublicanSen. James Lankford, Oklahoma

What the bill does

This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA).

Summary by the Congressional Research Service, Jul 22, 2026.

BillFull text · congress.gov(opens in a new tab)

Read the bill

About 100 words

Contents

Sec. 1. Short title

This Act may be cited as the “Stem Cell Therapeutic and Research Reauthorization Act of 2026”.

Sec. 2. Reauthorization of the C.W. Bill Young Cell Transplantation Program

Section 379B of the Public Health Service Act (42 U.S.C. 274m) is amended—

(1) by striking “appropriated $31,009,000” and inserting the following:

“(1) $31,009,000”;

(2) in paragraph (1), as so inserted, by striking the period at the end and inserting “; and”; and

(3) by adding at the end the following:

“(2) $33,009,000 for each of fiscal years 2027 through 2031.”.

Sec. 3. Cord blood inventory

Section 2(g) of the Stem Cell Therapeutic and Research Act of 2005 (42 U.S.C. 274k note) is amended by striking “2026” and inserting “2031”.

Official text, Reported to Senate (Jun 22, 2026), from the Government Publishing Office via Congress.gov. Printed version (PDF) · All versions on Congress.gov

What the bill does

Summary by the Congressional Research Service, Jul 22, 2026.